Literature DB >> 8156283

Effects of cytokines on alkaline phosphatase and osteocalcin production, calcification and calcium release by human osteoblastic cells.

T Kuroki1, M Shingu, Y Koshihara, M Nobunaga.   

Abstract

We examined the effect of TNF-alpha, IL-1 beta and IL-6 on alkaline phosphatase (ALP) and osteocalcin (OC) production, calcification and calcium (Ca) release in human osteoblastic cell cultures obtained from human periosteum. The cells were cultured with varying concentrations of cytokines for 3 days. TNF-alpha and IL-1 beta significantly inhibited ALP production, decreased cellular Ca content, and significantly enhanced 45Ca release in human osteoblastic cells. IL-6, on the other hand, significantly suppressed 45Ca release by osteoblastic cells. These cytokines did not influence the production of OC by osteoblastic cells. The results obtained suggest that TNF-alpha and IL-1 beta may inhibit bone formation and calcification and that the effects of IL-6 on osteoblastic cells may be different from those of TNF-alpha or IL-1 beta. These effects on osteoblastic cells may be one of the mechanisms by which bone loss occurs in patients with RA.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8156283     DOI: 10.1093/rheumatology/33.3.224

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  13 in total

1.  Regulation of periodontal ligament cell functions by interleukin-1beta.

Authors:  S Agarwal; C S Chandra; N P Piesco; H H Langkamp; L Bowen; C Baran
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

2.  Highly osteogenic PDL stem cell clones specifically express elevated levels of ICAM1, ITGB1 and TERT.

Authors:  Laddawun Sununliganon; Weerachai Singhatanadgit
Journal:  Cytotechnology       Date:  2011-08-25       Impact factor: 2.058

Review 3.  [Inflammation and bone metabolism in rheumatoid arthritis. Pathogenetic viewpoints and therapeutic possibilities].

Authors:  P Oelzner; G Hein
Journal:  Med Klin (Munich)       Date:  1997-10-15

Review 4.  Bone damage in rheumatoid arthritis: mechanistic insights and approaches to prevention.

Authors:  Sougata Karmakar; Jonathan Kay; Ellen M Gravallese
Journal:  Rheum Dis Clin North Am       Date:  2010-05       Impact factor: 2.670

5.  Comparison of osteogenic differentiation of embryonic stem cells and primary osteoblasts revealed by responses to IL-1β, TNF-α, and IFN-γ.

Authors:  Laura E Sidney; Glen R Kirkham; Lee D Buttery
Journal:  Stem Cells Dev       Date:  2014-01-23       Impact factor: 3.272

6.  Serum levels of IL-6, IL-10, IL-12, IL-17 and IFN-γ and their association with markers of bone metabolism in vitamin D-deficient female students.

Authors:  Zahra Jamali; Mohammad Kazemi Arababadi; Gholamreza Asadikaram
Journal:  Inflammation       Date:  2013-02       Impact factor: 4.092

7.  Repair of local bone erosions and reversal of systemic bone loss upon therapy with anti-tumor necrosis factor in combination with osteoprotegerin or parathyroid hormone in tumor necrosis factor-mediated arthritis.

Authors:  Kurt Redlich; Birgit Görtz; Silvia Hayer; Jochen Zwerina; Nicholas Doerr; Paul Kostenuik; Helga Bergmeister; George Kollias; Günter Steiner; Josef S Smolen; Georg Schett
Journal:  Am J Pathol       Date:  2004-02       Impact factor: 4.307

8.  Action of IL-1beta during fracture healing.

Authors:  Jeffrey Lange; Anna Sapozhnikova; Chuanyong Lu; Diane Hu; Xin Li; Theodore Miclau; Ralph S Marcucio
Journal:  J Orthop Res       Date:  2010-06       Impact factor: 3.494

9.  Interpretation of biomarkers of bone metabolism in children: impact of growth velocity and body size in healthy children and chronic disease.

Authors:  Shamir Tuchman; Meena Thayu; Justine Shults; Babette S Zemel; Jon M Burnham; Mary B Leonard
Journal:  J Pediatr       Date:  2008-06-16       Impact factor: 4.406

10.  Prevention of bone mineral density loss in patients with rheumatoid arthritis treated with anti-TNFalpha therapy.

Authors:  Hubert Marotte; Pierre Miossec
Journal:  Biologics       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.